168 related articles for article (PubMed ID: 30693699)
21. C/EBPα deregulation as a paradigm for leukemogenesis.
Pulikkan JA; Tenen DG; Behre G
Leukemia; 2017 Nov; 31(11):2279-2285. PubMed ID: 28720765
[TBL] [Abstract][Full Text] [Related]
22. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
23. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.
Pulikkan JA; Dengler V; Peer Zada AA; Kawasaki A; Geletu M; Pasalic Z; Bohlander SK; Ryo A; Tenen DG; Behre G
Leukemia; 2010 May; 24(5):914-23. PubMed ID: 20376080
[TBL] [Abstract][Full Text] [Related]
24. Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα.
Sridhar R; Takei H; Syed R; Kobayashi IS; Hui LB; Kamal A; Tenen DG; Kobayashi SS
Molecules; 2018 Aug; 23(8):. PubMed ID: 30081475
[TBL] [Abstract][Full Text] [Related]
25. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
[TBL] [Abstract][Full Text] [Related]
26. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
27. [Roles of CEBPA mutation and expression abnormality in acute myeloid leukemia - review].
Wang LM; Xiao HW; Huang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1256-60. PubMed ID: 23114160
[TBL] [Abstract][Full Text] [Related]
28. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
[TBL] [Abstract][Full Text] [Related]
29. A C/ebpα isoform specific differentiation program in immortalized myelocytes.
Garcia-Cuellar MP; Akan S; Slany RK
Leukemia; 2023 Sep; 37(9):1850-1859. PubMed ID: 37532789
[TBL] [Abstract][Full Text] [Related]
30. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
31. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
32. Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1).
Rahn K; Abdallah AT; Gan L; Herbrich S; Sonntag R; Benitez O; Malaney P; Zhang X; Rodriguez AG; Brottem J; Marx G; Brümmendorf TH; Ostareck DH; Ostareck-Lederer A; Crysandt M; Post SM; Naarmann-de Vries IS
Biochim Biophys Acta Gene Regul Mech; 2024 Mar; 1867(1):195004. PubMed ID: 38008244
[TBL] [Abstract][Full Text] [Related]
33. CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice.
Lange AP; Almeida LY; Araújo Silva CL; Scheucher PS; Chahud F; Krause A; Bohlander SK; Rego EM
Braz J Med Biol Res; 2019; 52(6):e8424. PubMed ID: 31141090
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
Rishi L; Hannon M; Salomè M; Hasemann M; Frank AK; Campos J; Timoney J; O'Connor C; Cahill MR; Porse B; Keeshan K
Blood; 2014 Apr; 123(15):2389-400. PubMed ID: 24516045
[TBL] [Abstract][Full Text] [Related]
35. The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML.
Kaeferstein A; Krug U; Tiesmeier J; Aivado M; Faulhaber M; Stadler M; Krauter J; Germing U; Hofmann WK; Koeffler HP; Ganser A; Verbeek W
Leukemia; 2003 Feb; 17(2):343-9. PubMed ID: 12592334
[TBL] [Abstract][Full Text] [Related]
36. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
[TBL] [Abstract][Full Text] [Related]
37. CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.
Truong BT; Lee YJ; Lodie TA; Park DJ; Perrotti D; Watanabe N; Koeffler HP; Nakajima H; Tenen DG; Kogan SC
Blood; 2003 Feb; 101(3):1141-8. PubMed ID: 12393450
[TBL] [Abstract][Full Text] [Related]
38. CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation.
Röhrs S; Scherr M; Romani J; Zaborski M; Drexler HG; Quentmeier H
J Hematol Oncol; 2010 Apr; 3():15. PubMed ID: 20398252
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of CCAAT/Enhancer Binding Protein (C/EBP) Alpha (CEBPA) and Runt-Related Transcription Factor 1 (RUNX1) Expression in Patients with De Novo Acute Myeloid Leukemia.
Salarpour F; Goudarzipour K; Mohammadi MH; Ahmadzadeh A; Faraahi S; Farsani MA
Ann Hum Genet; 2017 Nov; 81(6):276-283. PubMed ID: 28895127
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of sumoylation on the activities of CCAAT enhancer binding protein alpha (C/EBPα) p42 versus p30 may contribute in part, to aberrant C/EBPα activity in acute leukemias.
Hankey W; Silver M; Sun BS; Zibello T; Berliner N; Khanna-Gupta A
Hematol Rep; 2011 Jan; 3(1):e5. PubMed ID: 22184527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
